1-8 of 8
Ruijuan Sun
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Parallel Comparison of the Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for Refractory and Relapsed T-ALL/Lbl Patients Who Achieved Complete Remission with CD7 CAR-T Versus Patients Who Achieved First Complete Remission with Chemotherapy before Transplantation

Xingyu Cao, Jianping Zhang, Yue Lu, Yanli Zhao, Deyan Liu, Min Xiong, Ruijuan Sun, Zhijie Wei, Jiarui Zhou, Xian Zhang, Junfang Yang, Hongxing Liu, Sr., Peihua Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3611.
https://doi.org/10.1182/blood-2023-185696
Published: 2023
Journal Articles

Efficacy and Safety Analysis of Prophylactic Brentuximab Vedotin Administration after Pediatric Acute Leukemia Haploidentical Hematopoietic Stem Cell Transplantation

Huili Zhu, Xingyu Cao, Yue Lu, Yanli Zhao, Jianping Zhang, Deyan Liu, Min Xiong, Ruijuan Sun, Hongxing Liu, Zhijie Wei
Journal: Blood
Blood (2023) 142 (Supplement 1): 7009.
https://doi.org/10.1182/blood-2023-184500
Published: 2023
Journal Articles

Analysis Benefits of a Second Allo-HSCT after CAR-T Cell Therapy in 97 Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Who Relapsed after a First Transplant

Xing-yu Cao, Jian-Ping Zhang, Yan-Li Zhao, Min Xiong, Jiarui Zhou, Yue Lu, Ruijuan Sun, Zhijie Wei, Deyan Liu, Xian Zhang, Junfang Yang, Peihua Lu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4802–4803.
https://doi.org/10.1182/blood-2022-166993
Published: 2022
Journal Articles

Significant Long-Term Benefits of CAR T-Cell Therapy Followed By a Second Allo-HSCT for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Who Relapsed after an Initial Transplant

Jianping Zhang, Junfang Yang, Xian Zhang, MD, Jingjing Li, Xingyu Cao, Yanli Zhao, Zhijie Wei, Deyan Liu, Min Xiong, Yue Lu, Jiarui Zhou, Ruijuan Sun, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-136014
Published: 2020
Journal Articles

Alternative Donor and Disease-Specific Conditioning Regimen Hematopoietic Stem Cell Transplantation for Inherited Bone Marrow Failure Syndromes

Fang Xu, Min Xiong, Ruijuan Sun, Yanli Zhao, Jianping Zhang, Xingyu Cao, Deyan Liu, Zhijie Wei, Jiarui Zhou, Yue Lu, Peihua Lu, Daopei Lu
Journal: Blood
Blood (2019) 134 (Supplement_1): 2047.
https://doi.org/10.1182/blood-2019-125695
Published: 2019
Journal Articles

CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia

Yanli Zhao, Jianping Zhang, Deyan Liu, Min Xiong, Zhijie Wei, Ruijuan Sun, Jiarui Zhou, Yue Lu, Xingyu Cao, Junfang Yang, MD, Xian Zhang, PhD, Hui Wang, PhD, Hongxing Liu, MD, Peihua Lu, Daopei Lu
Journal: Blood
Blood (2018) 132 (Supplement 1): 2660.
https://doi.org/10.1182/blood-2018-99-118852
Published: 2018
Journal Articles

Allogeneic Transplantation for Minimal Residual Disease Negative Acute Lymphoblastic Leukemia According to 2016 Who Classification: A Single Center Retrospective Analysis

Xingyu Cao, Deyan Liu, Jianping Zhang, Zhijie Wei, Min Xiong, Yue Lu, Yanli Zhao, Jiarui Zhou, Ruijuan Sun, Hongxing Liu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5786.
https://doi.org/10.1182/blood-2018-99-116119
Published: 2018
Journal Articles

Unmanipulated Haploidentical Transplant for Acquired Severe Aplastic Anemia Achieved Comparable Outcomes with Unrelated Donor Transplant in Adult and Children Patients

Yue Lu, Ruijuan Sun, MD, Yanli Zhao, Xingyu Cao, Min Xiong, Jiangping Zhang, Dao-Pei Lu, MD, Hongxing Liu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4565.
https://doi.org/10.1182/blood.V130.Suppl_1.4565.4565
Published: 2017